<html xmlns:v="urn:schemas-microsoft-com:vml" xmlns:o="urn:schemas-microsoft-com:office:office" xmlns:w="urn:schemas-microsoft-com:office:word" xmlns:m="http://schemas.microsoft.com/office/2004/12/omml" xmlns="http://www.w3.org/TR/REC-html40"><head><meta http-equiv=Content-Type content="text/html; charset=us-ascii"><meta name=Generator content="Microsoft Word 12 (filtered medium)"><style><!--
/* Font Definitions */
@font-face
{font-family:"Cambria Math";
panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
{font-family:Calibri;
panose-1:2 15 5 2 2 2 4 3 2 4;}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
{margin:0cm;
margin-bottom:.0001pt;
font-size:12.0pt;
font-family:"Times New Roman","serif";}
a:link, span.MsoHyperlink
{mso-style-priority:99;
color:blue;
text-decoration:underline;}
a:visited, span.MsoHyperlinkFollowed
{mso-style-priority:99;
color:purple;
text-decoration:underline;}
span.apple-style-span
{mso-style-name:apple-style-span;}
span.EmailStyle18
{mso-style-type:personal-reply;
font-family:"Calibri","sans-serif";
color:#1F497D;}
.MsoChpDefault
{mso-style-type:export-only;
font-size:10.0pt;}
@page WordSection1
{size:612.0pt 792.0pt;
margin:70.85pt 70.85pt 70.85pt 70.85pt;}
div.WordSection1
{page:WordSection1;}
--></style><!--[if gte mso 9]><xml>
<o:shapedefaults v:ext="edit" spidmax="1026" />
</xml><![endif]--><!--[if gte mso 9]><xml>
<o:shapelayout v:ext="edit">
<o:idmap v:ext="edit" data="1" />
</o:shapelayout></xml><![endif]--></head><body lang=NL-BE link=blue vlink=purple style='word-wrap: break-word;-webkit-nbsp-mode: space;-webkit-line-break: after-white-space'><div class=WordSection1><div><p class=MsoNormal><span lang=EN-GB style='font-family:"Calibri","sans-serif"'>I am leading a small research team in Maastricht, and in co-operation with the dep. of clinical genetics, we have recently obtained a post doc position in oncogenomics (see attachment). The project will be based on the use of Next Generation Sequencing</span><span style='font-family:"Calibri","sans-serif"'> for the identification of additional genetic factors that can modify the cancer risks in carriers of Lynch syndrome mutations. Special focus will be put in Endometrial cancer.</span><span lang=EN-GB style='font-family:"Calibri","sans-serif"'><o:p></o:p></span></p></div><div><div><p class=MsoNormal><span lang=EN-GB style='font-family:"Calibri","sans-serif"'><o:p> </o:p></span></p></div><div><p class=MsoNormal><span lang=EN-GB style='font-family:"Calibri","sans-serif"'>Since our expertise on database and bioinformatics analysis is poor, we are looking for candidates who may have some background and experiences in bioinformatics, biostatistics, genetics etc. Therefore, I would like to ask you whether you can let this announcement circulate at your university or if you have any candidate in mind, who may be willing to come over Maastricht for a couple of years.<o:p></o:p></span></p></div><div><p class=MsoNormal><span lang=EN-GB style='font-family:"Calibri","sans-serif"'><o:p> </o:p></span></p></div><div><p class=MsoNormal><span lang=EN-GB style='font-family:"Calibri","sans-serif"'>I thank you in advance and I am looking forward to hearing from you.<o:p></o:p></span></p></div><div><p class=MsoNormal><span lang=EN-GB style='font-family:"Calibri","sans-serif"'><o:p> </o:p></span></p></div><div><p class=MsoNormal><span lang=EN-GB style='font-family:"Calibri","sans-serif"'>Best, Andrea Romano<o:p></o:p></span></p></div></div><p class=MsoNormal><span lang=EN-GB style='font-family:"Calibri","sans-serif"'><o:p> </o:p></span></p></div></body></html>